The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind
Supramaximal resection beyond the contrast-enhancing tumor borders represents an emerging surgical strategy for patients with newly diagnosed glioblastoma. A recent study provides evidence detailing the interactive effects of more aggressive surgery on other clinical predictors of outcome, supporting guidance for surgical decision-making and informing clinical trialists about the need to stratify for extent of resection. See related article by Park et al., p. 4866.
Authors
- J. C. Tonn (ORCID: https://orcid.org/0009-0004-1756-423X)
- Daniel P. Cahill (ORCID: https://orcid.org/0000-0003-2552-6546)
- Philipp Karschnia (ORCID: https://orcid.org/0000-0002-1254-5310)
Institutions
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Massachusetts General Hospital (US)
- Universitätsklinikum Erlangen (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2024-08-20
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-1819
- Citations
- 5
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.19